D043823Chemicals & DrugsD02.455.426.392.368.242.888D02.455.849.291.8507140.990557TaxoidsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersontrue1Assistant ProfessorAssistant ProfessorMichaelJelinekMichael Jelinek350072Jelinek, MichaelAssistant Professor0.9457870.01320937research area of0.6158940.05334116subject area forOtolaryngologyPhilipBonomiPhilip Bonomi349183Bonomi, PhilipProfessorMelodyCobleighMelody Cobleigh349588Cobleigh, MelodyProfessorMary JoFidlerMary Jo Fidler349589Fidler, Mary JoAssociate ProfessorKerstinStensonKerstin Stenson349681Stenson, KerstinProfessor6Assistant Professor5Associate Professor4Professor18475293Paz-Ares L, Ross H, O'Brien M, Riviere A, Gatzemeier U, Von Pawel J, Kaukel E, Freitag L, Digel W, Bischoff H, Garc?a-Campelo R, Iannotti N, Reiterer P, Bover I, Prendiville J, Eisenfeld AJ, Oldham FB, Bandstra B, Singer JW, Bonomi PBritish journal of cancerPhase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer. 2008 May 20; 98(10):1608-13.Br J Cancer2008-05-13T00:00:002008Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.19446501Chen SS, Strauss JB, Shah AP, Rao RD, Bernard DA, Griem KLBrachytherapyRadiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009 Jul-Sep; 8(3):331-4.Brachytherapy2009-05-15T00:00:002009Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy.17882655Seiwert TY, Cohen EE, Haraf DJ, Stenson K, Blair EA, Mauer A, Dekker A, Vokes EECancer investigationA phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer. Cancer Invest. 2007 Sep; 25(6):435-44.Cancer Invest2007-09-01T00:00:002007A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.26712084Herbst RS, Baas P, Kim DW, Felip E, P?rez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, de Castro G, Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EBLancet (London, England)Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016 Apr 09; 387(10027):1540-1550.Lancet2015-12-19T00:00:002015Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.Internal MedicineRush University, Rush Medical CollegeInternal Medicine, Division of Hematology/Oncology/Cell Therapytrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor28373418Jelinek M, Kabelova A, Sramek J, Seitz J, Ojima I, Kovar JAnticancer researchDiffering Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017 04; 37(4):1581-1590.Anticancer Res2017-04-01T00:00:002017Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells.